Lori Mills, Radio Talk Show Host at Uncover California, Real Estate Consultant, Keller Williams World Class Westlake Village, shared a post on X:
“My husband was diagnosed with glioblastoma and given 12 months to live.
He has been on ANKTIVA and PDL-1 NK infusions. He has now had 2 normal brain scans.
The red tape to ground breaking therapy needs to be cut! The fact the FDA wrote Dr Pat a letter to silence him is a disgrace.
People deserve to choose the path that makes sense to them. They deserve hope! They shouldn’t have to fail standard therapy to be given a chance at life. The first MRI is before, the 2nd after.”
Mills‘ commentary was prompted by Marty Makary, the 27th Commissioner of the U.S. FDA, who pointed out the efficiency of the system when ‘expanded access’ is triggered:
“Two Days after receiving the application, FDA greenlit the new pancreatic cancer drug daraxonrasib for expanded access.
This drug has also been granted a national priority voucher, which means a full application could be reviewed in a matter of weeks instead of 10-12 months.”
Other articles featuring Lori Mills and Marty Makary on OncoDaily.
